Summary of Regulatory Response
Solara Active Pharma Sciences Limited has issued a formal response to the National Stock Exchange of India Limited (NSE) regarding a surveillance query about unusual trading activity in the company's securities.
Date and Nature of Query
- Date of Company Communication: June 10, 2026
- Date of NSE Query: June 09, 2026 (Ref. No.: NSE/CM/Surveillance/17074)
- Nature of Query: The NSE sought clarification from the company regarding a "significant increase in the volume of the securities of the Company across exchanges in the recent past."
Company’s Clarification on Trading Volume
The company, through its Compliance Officer, clarified that it has not withheld any material information or event that, in its opinion, would have a bearing on the price or volume behavior of its scrip. The response states that all required disclosures have been made in compliance with regulatory requirements.
Reference to Regulatory Compliance
The company specifically references its compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This confirms that the company's response is framed within the context of its ongoing obligations to disclose material events to the market.
Details of Financial Results Clarification
The document provided does not contain any details, clarifications, or discussions related to financial results. The query and response are solely focused on the trading volume activity and the company's confirmation of adequate disclosure compliance.
Sentiment & Topic Tags
Topics: Regulatory Response, Stock Trading, Volume Increase, Compliance, SEBI LODR